:
LIVE on MediaMedic | July 2–4
Central European Time: 15:00–16:00 | China Standard Time: 21:00–22:00
Join us for the 2025 Pujiang Prostate Cancer Academic Conference, broadcasting live on MediaMedic. Under the theme “Global Wisdom, Chinese Practice, Precision Breakthrough,” this year’s event brings together world-leading experts to share the latest innovations transforming prostate cancer care.
The conference highlights China’s remarkable progress—raising the five-year survival rate to 82.6%, with nearly 100% for early-stage patients—driven by multi-omics precision typing, innovative endocrine therapies, surgical robotics, and nuclear medicine.
On July 2, the focus is on radical prostatectomy techniques and new strategies for managing mCRPC. July 3 explores advancements in minimally invasive surgery, including robot-assisted procedures and AI-guided diagnostics. July 4 spotlights multidisciplinary breakthroughs, with key discussions on AI-driven diagnostic systems, deuterium-based therapies, and biopsy-free approaches, followed by a dynamic expert panel.
With insights from leaders such as Dingwei Ye, Philip Kwong, Kan Gong, Yao Zhu, and Feng Zhou, the sessions offer a front-row view of how China is shaping the global prostate cancer landscape. Expect exclusive guideline updates, real-world clinical strategies, and emerging innovations like Nuclear Theranostics and homegrown robotic surgery.
Stream the full program live on MediaMedic and take part in shaping the future of prostate cancer care—where survival and quality of life are enhanced together.
Live only on MediaMedic
